Leslie M. Randall
Papers
2
Total Citations
32
H-Index
2
About
Leslie M. Randall is a leading gynecologic oncologist whose research centers on improving surgical outcomes for women with gynecologic cancers, particularly cervical cancer. She is best known for her pivotal role in the ROCC/GOG-3043 trial, a landmark randomized non-inferiority study comparing robotic versus open radical hysterectomy for early-stage cervical cancer. This work directly addresses the critical safety questions raised by the 2018 LACC trial, which found worse outcomes with laparoscopic surgery. By rigorously evaluating robotic surgery’s oncologic safety, Randall’s research provides essential evidence guiding surgical decision-making. Her contributions have garnered significant attention, with the 2022 trial protocol accumulating 24 citations and the 2025 results paper already cited 8 times, reflecting the field’s urgent need for clarity. Randall’s work not only advances surgical technique but also prioritizes patient safety and quality of life, making her a key voice in the ongoing evolution of minimally invasive gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2